Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients
EFICANCER
PHYSICAL EXERCISE TO IMPROVE THE QUALITY OF LIFE OF CANCER PATIENTS DURING TREATMENT PROCESS: EFICANCER STUDY
1 other identifier
interventional
250
1 country
1
Brief Summary
AIM: To evaluate the effectiveness and efficiency of an innovative exercise program (EP) for patients during treatment for gastrointestinal tumors, breast and non small cells lung cancer, in terms of improved quality of life (QOL), fatigue and functional capacity respect the usual standard treatment (ST). DESIGN: Pragmatic randomized clinical trial in two parallel groups: EP and ST. SETTING: 7 Primary Health Centers (PHC) of the redIAPPISCIII, in coordination with oncology services. PARTICIPANTS: 250 patients with the above tumors, locally advanced or with metastatic disease, in adjuvant treatment, with Performance Status(PS) PS1-PS0. INTERVENTION: Both groups received standardized usual care. The EP group will receive, in addition, a nurse supervised exercise program for 2 months in the PHC and a second phase in community facilities during the remaining 10 months. MEASUREMENTS: The primary outcome measure is the change from baseline in the QOL+66 treatment, as measured by the specific questionnaire for patients with cancer EORTC QLQ-C-30 and Short Form(SF-36) overall. Secondary: fatigue (FACIT-F), radiological response, functional capacity (6 minutes walking and cardiopulmonary test), muscle strength and progression-free survival and overall. Predictors and confounders: age, sex, stage and tumor type, histology, treatment. ANALYSIS: We will compare between groups mean changes from baseline measurement of quality of life questionnaire (QOL) and other variables, on an intention to treat basis, using longitudinal mixed-effects models for repeated measures at 2, 6 and 12 months follow-up. Cost / effectiveness and cost / incremental utility associated to the program wil be estimated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2013
CompletedFirst Posted
Study publicly available on registry
February 7, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJuly 23, 2014
July 1, 2014
1.8 years
February 5, 2013
July 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Health Related Quality of Life (EORTC QLQ-C30)
basal,2,6,12 months fllow up
Secondary Outcomes (5)
asthenia measurement with FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) questionaire
Basal, 2,6 and12 months
Functional Capacity-6 minute Walking test
basal, 2,6 and 12 months
cardiorespiratory test
basal, 2, 6 and12 months
Changes in Muscular Strenght-Dynamometer
basal, 2,6 nad 12 months
progression-free survival
basal, 2, 6 and 12 months
Study Arms (2)
Exercise group
EXPERIMENTALsupervised exercise program education program on healthy habits Pharmacological treatment and selfcare encouragement
control group
NO INTERVENTIONPharmacological treatment and selfcare encouragement.
Interventions
Both groups received standardized usual care. The EP group will receive, in addition, a nurse supervised exercise program for 2 months in the PHC and a second phase in community facilities during the remaining 10 month
education program on healthy habits for 2 months in the PHC and a second phase in community facilities during the remaining 10 months
Eligibility Criteria
You may qualify if:
- Age between 18-70 years
- Diagnosis of digestive system cancer , breast cancer or histologically confirmed NSCLC stage IV Physical Status (PS) 0 or 1.
- First-line chemotherapy treatment for each type of standard tumor
- Adequate renal, liver and blood function.
You may not qualify if:
- Brain metastases
- Risk of fracture (bone metastases)
- Unstable heart disease, uncontrolled BP Systolic Blood Pressure((SBP)\> 200 or Diastolic Blood Pressure (DBP)\> 110), heart failure (NYHA II or greater), constrictive pericarditis
- Other diseases at the discretion of the investigator to be a contraindication for physical exercise.
- Perform regular physical activity (150 minutes / week of moderate or vigorous 75)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Primary Care Research Unit of Bizkaia
Bilbao, Bizkaia, 48014, Spain
Related Publications (2)
Mendizabal-Gallastegui N, Arietaleanizbeaskoa MS, Latorre PM, Garcia-Alvarez A, Sancho A, Iruarrizaga E, Lopez-Vivanco G, Grandes G. Nurse-Supervised Exercise for People with Stage IV Cancer: The EFICANCER Randomized Clinical Trial. Semin Oncol Nurs. 2023 Aug;39(4):151448. doi: 10.1016/j.soncn.2023.151448. Epub 2023 May 13.
PMID: 37183104DERIVEDSancho A, Carrera S, Arietaleanizbeascoa M, Arce V, Gallastegui NM, Gine March A, Sanz-Guinea A, Eskisabel A, Rodriguez AL, Martin RA, Lopez-Vivanco G, Grandes G. Supervised physical exercise to improve the quality of life of cancer patients: the EFICANCER randomised controlled trial. BMC Cancer. 2015 Feb 6;15:40. doi: 10.1186/s12885-015-1055-x.
PMID: 25655792DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
GRANDES GONZALO, Medicine
Primary Care Research Unit of Bizkaia (Basque Health Service)
- STUDY DIRECTOR
ARIETALEANIZBEASCOA MARIA SOLEDAD, NURSE
Primary Care Research Unit of Bizkaia (Basque Health Service)
Central Study Contacts
Maria Soledad Arietaleanisbeaskoa, Nurse
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Family Medicine specialist, master in epidemiology; Head of the Research Unit of Family Medicine of Bizkaia
Study Record Dates
First Submitted
February 5, 2013
First Posted
February 7, 2013
Study Start
April 1, 2013
Primary Completion
January 1, 2015
Study Completion
December 1, 2015
Last Updated
July 23, 2014
Record last verified: 2014-07